Attendees of the ‘Ensuring Drug Security’ Forum discussed issues of public trust in the Russian pharmaceutical products
Vladislav Shestakov, Director of the State Institute of Drugs and Good Practices of the Russian Ministry of Industry and Trade, took part in the session ‘Made in Russia. How can domestic pharmaceutical products win over consumer trust’? of the Russian Pharmaceutical Forum, held on June 5 within the framework of SPIEF-2024 in Saint Petersburg.
;
The main discussion topic among the session participants was the strategy for building the reputation of the Russian pharmaceutical industry, which should be based on the constructive interaction between the regulators, the pharmaceutical business, and the professional and scientific community in the interests of the Russian citizens.
During his speech, Vladislav Shestakov noted that it is important for the industry, medical and patient community to enter into an open dialogue.
“The Russian pharmaceutical industry has made a significant technological advancement. Our regulatory standards on pharmaceutical production and quality assurance comply with the best global practices; the majority of the Russian manufacturers use modern high-tech equipment. Domestically produced pharmaceutical products are not inferior in quality, effectiveness and safety than the foreign ones. This has been proven during the issuance of manufacturing authorizations, monitoring of production conditions and subsequent market oversight,” emphasized Vladislav Shestakov.
Speaking about the importance of maintaining trust with patients, Vladislav Shestakov noted that it is important to enter into a direct open dialogue with the patient community and establish close connection between the manufacturers and physicians. “We need to demonstrate that the domestic drug manufacturers are high-tech companies that invest heavily in research and development, and their production sites are equipped with the state-of-the-art equipment, actually, unlike a number of foreign enterprises that were established long time ago,” Vladislav Shestakov noted during his speech.
Other materials
- The importance of reference samples in the development of pharmaceutical industry was discussed during the meeting of the Healthcare Commission of the General Council of the UNITED RUSSIA Party
- The program of the IX All-Russian GMP Conference with international participation has been published
- Vladislav Shestakov took part in the 8th International Pharmaceutical Congress Russia – Nicaragua “Evolution of Production Potential: Localization of Production to Strengthen the International Health Care System”
- The 31st N.A. Semashko Russian Pharmaceutical Forum was held in Saint Petersburg on May 14-15, 2024 with the support of the FSI “SID&GP” of the Ministry of Industry and Trade of Russia
- The expansion of cooperation in the pharmaceutical and medical industries discussed at the INNOPROM. Central Asia international exhibition